Cargando…

Assessments tools for risk prediction of cardiovascular diseases

SCIENTIFIC BACKGROUND: Cardiovascular diseases have an enormous epidemiological and economic importance. For the selection of persons with increased total cardiovascular risk for individual-targeted (e. g. drug-based) prevention interventions different risk prognosis instruments (equations, point sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorenoi, Vitali, Schönermark, Matthias P., Hagen, Anja
Formato:	Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011279/ https://www.ncbi.nlm.nih.gov/pubmed/21289898 http://dx.doi.org/10.3205/hta000073

Ejemplares similares

Benefits and risks of hormonal contraception for women
por: Gorenoi, Vitali, et al.
Publicado: (2007)

Arthroplasty register for Germany
por: Gorenoi, Vitali, et al.
Publicado: (2009)

Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes
por: Gorenoi, Vitali, et al.
Publicado: (2008)

CT coronary angiography vs. invasive coronary angiography in CHD
por: Gorenoi, Vitali, et al.
Publicado: (2012)

Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris
por: Gorenoi, Vitali, et al.
Publicado: (2011)

Bone graft substitutes for the treatment of traumatic fractures of the extremities
por: Hagen, Anja, et al.
Publicado: (2012)

Specific immunotherapy (SIT) in the treatment of allergic rhinitis
por: Hagen, Anja, et al.
Publicado: (2010)

Prevention of infection after knee arthroplasty
por: Gorenoi, Vitali, et al.
Publicado: (2010)

Intravascular brachytherapy for peripheral vascular disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2008)

Laparoscopic vs. open appendectomy: systematic review of medical efficacy and health economic analysis
por: Gorenoi, Vitali, et al.
Publicado: (2007)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Methods for assessment of innovative medical technologies during early stages of development
por: Bartelmes, Marc, et al.
Publicado: (2009)

Procedures and Criteria for the regulation of innovative non-medicinal technologies into the benefit catalogue of solidly financed health care insurances
por: Neumann, Ulrike, et al.
Publicado: (2008)

Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
por: Gorenoi, Vitali, et al.
Publicado: (2006)

Cardiovascular risk assessment tools in Asia
por: Zhang, Yuqing, et al.
Publicado: (2022)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Regional product factory: a format to address regional health care deficits by developing innovative integrated care models
por: Schönermark, Matthias P., et al.
Publicado: (2009)

Novel Self‐Report Tool for Cardiovascular Risk Assessment
por: Mansoor, Hend, et al.
Publicado: (2019)

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases
por: Rosolova, Hana, et al.
Publicado: (2011)

Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol
por: Taljaard, Monica, et al.
Publicado: (2014)

Cardiovascular Risk Prediction by the American Diabetes Association Risk-Assessment Tool and Novel and Traditional Cardiovascular Risk Factors in Young Adults With Type 1 Diabetes
por: Inácio, Isabel, et al.
Publicado: (2022)

One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease
por: Alssema, Marjan, et al.
Publicado: (2012)

Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
por: Drosos, George C, et al.
Publicado: (2023)

Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients
por: Jung-Poppe, Lea, et al.
Publicado: (2022)

Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population
por: Oulhaj, Abderrahim, et al.
Publicado: (2020)

Mansoor's Self‐Report Tool for Cardiovascular Risk Assessment predicts adverse in‐hospital events in patients with pulmonary embolism
por: Keller, Karsten, et al.
Publicado: (2022)

An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England
por: Pate, Alexander, et al.
Publicado: (2020)

Potential of thermal imaging as a tool for prediction of cardiovascular disease
por: Thiruvengadam, Jayanthi, et al.
Publicado: (2014)

Computational in silico genetic variant prediction tools in cardiovascular disease
por: Hellwig, Lydia D., et al.
Publicado: (2023)

Tools and scores for general and cardiovascular perioperative risk assessment: a narrative review
por: MORAES, CAIO MAZZONETTO TEÓFILO DE, et al.
Publicado: (2022)

Cardiovascular disease risk prediction in scleroderma
por: Çelikkol, Aliye, et al.
Publicado: (2023)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
por: Livingstone, Shona, et al.
Publicado: (2023)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

Evaluation of cardiovascular risk in adult psychiatric outpatients in Qatar using two risk assessment tools
por: Al-Rawi, Safa, et al.
Publicado: (2021)

Tools for Assessing Cardiovascular Disease Risk Factors in Underserved Young Adult Populations: A Systematic Review
por: Opoku-Acheampong, Audrey A., et al.
Publicado: (2021)

Role of Fracture Risk Assessment Tool and Bone Turnover Markers in Predicting All-Cause and Cardiovascular Mortality in Hemodialysis Patients
por: Wu, Pei-Yu, et al.
Publicado: (2022)

The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
por: Provenzano, Michele, et al.
Publicado: (2020)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Tools for the Assessment of the Malnutrition Status and Possible Interventions in Elderly with Cardiovascular Diseases
por: Tonet, Elisabetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hale1nsmjp4c0r68em7lpfaevg